Deep learning application to automatic classification of recommendations made by hospital pharmacists during drug prescription review

Author:

Alkanj Ahmad1,Godet Julien2,Johns Erin1,Gourieux Bénédicte3,Michel Bruno1

Affiliation:

1. Laboratoire de Pharmacologie et Toxicologie NeuroCardiovasculaire UR7296

2. Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie

3. Hôpitaux Universitaires de Strasbourg

Abstract

Abstract Purpose: Recommendations to improve therapeutics (Recos) are proposals made by pharmacists during the prescription review process to address sub-optimal use of medicines. In hospitals, Recos are generated daily as text documents that are sent to prescribers. If collected Recos data were easier and less time-consuming to summarize, they could be used retrospectively to improve safeguards for better prescribing. The objective of this work was to train a deep learning algorithm for automatic Recos classification in order to value the large amount of Recos data. Methods: The study was conducted at the University Hospital of Strasbourg. Recos data were collected throughout 2017. Data from the first six months of 2017 were labeled by two pharmacists who assigned to each of the Recos one of the 29 possible classes of the French Society of Clinical Pharmacy classification. A deep neural network classifier was trained to predict the class of Recos from the raw text data. Results: 27,699 labeled Recos from the first half of 2017 were used to train and evaluate a classifier. The prediction accuracy calculated on a validation data set was 78.0%. We predicted classes for the unlabeled Recos collected during the second half of 2017. Of the 4,460 predictions reviewed, 67 required corrections. After these additional labeled data were concatenated with the original data set and the neural network re-trained, accuracy reached 81.0 %. Conclusions: We report an efficient automatic classification of Recos. Making retrospective prescription review data easier to understand should enable better anticipation of prescription-related problems in future prescriptions, thereby improving patient safety.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3